The Company designs, develops, manufactures and markets reconstructive orthopaedic implants, including joint and dental, spinal implants, trauma products and related orthopaedic surgical products.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Large numbers of active older persons who will be more likely to need hip/knee prostheses or replacements. Baby boomers will be biggest source of customers. As a Zimmer knee implantee, I can personally vouch for the quality of the product.
With wide moat numbers such as Op margin of 33.9%, no ttm debt, nearly 30% of orthopedic joint market share, and stair step growth in earnings and FCF. I think it will handily outgrow the S&P over the next several years and may even get stronger as the active boomers get older.